Ellen Hukkelhoven

Head of Biotechnology Investments at Perceptive Advisors

Ellen Hukkelhoven joined Perceptive in 2013 as a Senior Biotechnology Analyst. At Perceptive, she focuses on public and private development stage therapeutic companies. Ellen serves on the boards of MeiraGTx, Freenome, Kindbody, AavantiBio and Partner Therapeutics. She is also a member of the Board of Overseers of the Columbia Mailman School of Public Health. Prior to Perceptive, Ellen received her PhD in Cancer Biology from Memorial Sloan Kettering Cancer Center. During her tenure at MSKCC, she founded and built the life sciences division of InSITE, a top graduate fellowship program that helps early stage companies with their most pressing needs. Ellen graduated magna cum laude from Princeton University with degrees in molecular biology and finance.

Org chart

Manager

Adam Stone

Chief Investment Officer & Head of Research

Peers

Konstantin Poukalov

Managing Director & Co-Head, Perceptive Discovery

Tatiana Gonzalez

Executive Assistant, Research

Michael Altman

Managing Director, Med Devices, Diagnostics & MedTech

Reports

Gabriel Sokoloff

Analyst, Biotechnology

Kriti Lall

Analyst, Biotechnology

Timeline

Head of Biotechnology Investments
Current role
Managing Director
Managing Director, Biotechnology

View in org chart